Sponsors / NVAX
NVAX

Novavax

Company identity has not yet been verified

Browse linked trials and recorded changes, or follow this company for updates.

Follow company
13Trials in this database
5Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source
TrialSponsorPhaseStatusPrimary completion
A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal ImmunizationNCT02624947NovavaxPhase 3Completed2018-12-28Actual
A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United KingdomNCT04583995NovavaxPhase 3Completed2022-03-29Actual
A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2NCT04611802NovavaxPhase 3Completed2023-04-10Actual
Phase 3 Boosting Study for the SARS-CoV-2 rS Variant VaccinesNCT05372588NovavaxPhase 3Completed2022-07-17Actual
Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in AdultsNCT05463068NovavaxPhase 3Completed2022-08-17Actual
Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 YearsNCT05468736NovavaxPhase 2, Phase 3Completed2024-01-16Actual
A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination VaccineNCT05519839NovavaxPhase 2Completed2023-07-25Actual
Phase 3 Study of Novavax Vaccine(s) as Booster Dose After mRNA VaccinesNCT05875701NovavaxPhase 3Completed2023-11-11Actual
Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS VaccinesNCT05925127NovavaxPhase 2, Phase 3Completed2024-05-21Actual
Phase 3 Adolescent Study for SARS-CoV-2 rS Variant VaccinesNCT05973006NovavaxPhase 3Completed2024-04-01Actual
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.NCT05975060NovavaxPhase 2, Phase 3Completed2023-11-15Actual
A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination VaccineNCT06291857NovavaxPhase 3Completed2025-12-24Actual
A Strain Change Study for SARS-CoV-2 rS VaccinesNCT06409663NovavaxPhase 3Completed2024-10-15Actual

Latest recorded trial changes